CN Stock MarketDetailed Quotes

Shandong Jincheng Pharmaceutical Group (300233)

Watchlist
  • 15.10
  • +0.22+1.48%
Market Closed Jan 12 15:00 CST
5.80BMarket Cap75.12P/E (TTM)

Shandong Jincheng Pharmaceutical Group (300233) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Preparation product470.46M34.59%
Other pharmaceutical and chemical products361.99M26.61%
Cefazal side chain active ester series297.6M21.88%
Series of Biopharmaceutical and characteristic API products230.2M16.92%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Intermediate segment662.94M48.74%
Preparation division476.16M35.01%
Characteristic raw material medicine235.35M17.30%
Other17.66M1.30%
Interdivisional offset-31.87M-2.34%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic sales1.13B82.92%
Foreign sales232.35M17.08%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More